Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Letsch

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2024
The effect of social care nurses on health related quality of life in patients with advanced cancer: A non-randomized, multicenter, controlled trialDaniel Schindel, Johann Frick, Pimrapat Gebert, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 3, 2013
Doublets pretending to be CD34+ T cells despite doublet exclusionRobert Friedrich Kudernatsch, Anne Letsch, Harald Stachelscheid, et al.
Psycho-Oncology|September 1, 2020
Perspectives of patients with multiple myeloma on accepting their prognosis-A qualitative interview studyMyriel Hermann, Franziska Kühne, Amy Rohrmoser, et al.
Cancer Medicine|January 9, 2023
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance dataDaniel Schindel, Pimrapat Gebert, Johann Frick, et al.
Cancer Research|September 23, 2003
Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cellsAnne Letsch, Ulrich Keilholz, Geraldine Assfalg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Specific central memory T cells in the bone marrow of patients immunized against tyrosinase peptidesAnne Letsch, Ulrich Keilholz, Florian Kern, et al.
Seminars in Cancer Biology|March 6, 2004
Rational peptide-based tumour vaccine development and T cell monitoringCarmen Scheibenbogen, Anne Letsch, Alexander Schmittel, et al.
Frontiers of Radiation Therapy and Oncology|January 6, 2006
Malignant melanoma--clinical development of peptide-based melanoma vaccinesAlexander Schmittel, Carmen Scheibenbogen, Anne Letsch, et al.
Palliative & Supportive Care|July 8, 2025
The caregiver's journey: A qualitative study on the integration of family caregivers of advanced cancer patients in outpatient settings in GermanyPetya Zyumbileva, Ute Goerling, Anne Letsch, et al.
Journal of Translational Medicine|January 23, 2010
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccinationAntonia Busse, Anne Letsch, Carmen Scheibenbogen, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2024
The effect of social care nurses on health related quality of life in patients with advanced cancer: A non-randomized, multicenter, controlled trialDaniel Schindel, Johann Frick, Pimrapat Gebert, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 3, 2013
Doublets pretending to be CD34+ T cells despite doublet exclusionRobert Friedrich Kudernatsch, Anne Letsch, Harald Stachelscheid, et al.
Psycho-Oncology|September 1, 2020
Perspectives of patients with multiple myeloma on accepting their prognosis-A qualitative interview studyMyriel Hermann, Franziska Kühne, Amy Rohrmoser, et al.
Cancer Medicine|January 9, 2023
Associations among navigational support and health care utilization and costs in patients with advanced cancer: An analysis based on administrative health insurance dataDaniel Schindel, Pimrapat Gebert, Johann Frick, et al.
Cancer Research|September 23, 2003
Bone marrow contains melanoma-reactive CD8+ effector T cells and, compared with peripheral blood, enriched numbers of melanoma-reactive CD8+ memory T cellsAnne Letsch, Ulrich Keilholz, Geraldine Assfalg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 15, 2006
Specific central memory T cells in the bone marrow of patients immunized against tyrosinase peptidesAnne Letsch, Ulrich Keilholz, Florian Kern, et al.
Seminars in Cancer Biology|March 6, 2004
Rational peptide-based tumour vaccine development and T cell monitoringCarmen Scheibenbogen, Anne Letsch, Alexander Schmittel, et al.
Frontiers of Radiation Therapy and Oncology|January 6, 2006
Malignant melanoma--clinical development of peptide-based melanoma vaccinesAlexander Schmittel, Carmen Scheibenbogen, Anne Letsch, et al.
Palliative & Supportive Care|July 8, 2025
The caregiver's journey: A qualitative study on the integration of family caregivers of advanced cancer patients in outpatient settings in GermanyPetya Zyumbileva, Ute Goerling, Anne Letsch, et al.
Journal of Translational Medicine|January 23, 2010
Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccinationAntonia Busse, Anne Letsch, Carmen Scheibenbogen, et al.
Pageof 9